Apixaban: A Review in Venous Thromboembolism.

Related ArticlesApixaban: A Review in Venous Thromboembolism.
Drugs. 2016 Sep 21;
Authors: Greig SL, Garnock-Jones KP
Abstract
Apixaban (Eliquis(®)) is an oral, direct factor Xa inhibitor that is available…

Efmoroctocog Alfa: A Review in Haemophilia A.

Efmoroctocog Alfa: A Review in Haemophilia A.
Drugs. 2016 Aug 3;
Authors: Frampton JE
Abstract
Efmoroctocog alfa (Elocta(®), Eloctate(®), Eloctate™), a first-in-class recombinant factor VIII-Fc f…

Fimasartan: A New Angiotensin Receptor Blocker.

Fimasartan: A New Angiotensin Receptor Blocker.
Drugs. 2016 Jun 7;
Authors: Lee HY, Oh BH
Abstract
Fimasartan is the ninth, and most recent, angiotensin II receptor antagonist approved as an antihypertens…

Reslizumab: First Global Approval.

Related ArticlesReslizumab: First Global Approval.
Drugs. 2016 Apr 28;
Authors: Markham A
Abstract
Reslizumab (Cinqair(®)) is a humanised monoclonal interleukin-5 (IL-5) antibody developed by Teva that has…

Top